Stock-Based Compensation (Tables)

12 Months Ended

Dec. 31, 2024

Share-Based Payment Arrangement, Cost by Plan

Stock-based compensation expense for the years ended December 31, 2024, 2023 and 2022 is as follows:


	Year Ended December 31,
(in thousands)	2024		2023		2022
Stock options	$	340	$	900	$	1,327
Restricted share units(1)(2)	35,734		161,216		158,031
Total stock-based compensation expense	36,074		162,116		159,358
Tax benefit recognized in the Consolidated Statements of Operations	5,483		5,168		3,391
Stock-based compensation expense, net of tax	$	30,591	$	156,948	$	155,967

(1) Includes expense of $4.9 million, $137.5 million and $143.2 million for the years ended December 31, 2024, 2023 and 2022, respectively in stock compensation expense related to 8,096,595 common shares issued to the former owners of Acima, as part of the Aggregate Stock Consideration subject to restricted stock agreements, and recorded to Other gains and charges in our Consolidated Statements of Operations. Shares issued as part of the Aggregate Stock Consideration for the acquisition of Acima Holdings were not issued under the authorization of the 2021 Plan or any prior approved long-term incentive plan described above. See Note N for additional information.

(2) Includes expense of $5.1 million for the year ended December 31, 2024 in stock compensation expense related to accelerated stock compensation due to the letter agreement entered into with the Company's Chief Executive Officer and recorded to Other gains and charges in our Consolidated Statements of Operations. See Note N for additional information.

Share-Based Payment Arrangement, Option and Stock Appreciation Rights, Activity

Information with respect to stock option activity related to the Plans for the year ended December 31, 2024 follows:


	Equity Awards Outstanding	Weighted Average Exercise Price		Weighted Average Remaining Contractual Life	Aggregate Intrinsic Value (in thousands)
Balance outstanding at January 1, 2024	655,643	$	22.36
Granted	—	—
Exercised	(73,152)	24.59
Forfeited	(3,996)	43.24
Expired	(15,501)	36.38
Balance outstanding at December 31, 2024	562,994	$	21.54	4.27	$	4,886

Exercisable at December 31, 2024	550,602	$	21.03	4.23	$	4,891

Schedule of Nonvested Restricted Stock Units Activity

Information with respect to non-vested restricted stock unit activity follows:


	Restricted Awards Outstanding	Weighted Average Grant Date Fair Value
Balance outstanding at January 1, 2024(1)	2,208,752	$	37.10
Granted	829,959	37.09
Vested(2)	(758,275)	48.28
Forfeited	(207,614)	57.99
Balance outstanding at December 31, 2024	2,072,822	$	30.91

(1) Includes 363,791 outstanding shares at January 1, 2024 related to RSA agreements issued as part of the Aggregate Stock Consideration for the acquisition of Acima Holdings, which were not issued under the authorization of the 2021 Plan or any previously approved long-term incentive plan described above. These RSA were fully vested during the year ended December 31, 2024.

(2) Includes 363,791 shares vested during 2024 as part of RSA agreements issued as part of the Aggregate Stock Consideration for the acquisition of Acima Holdings, as described above.